Bayesian Inference for the Parameters of Kumaraswamy Distribution via Ranked Set Sampling

Jiang, Huanmin; Gui, Wenhao

doi:10.3390/sym13071170

Cited by 9 publications

(3 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Since the prior distribution of the parameters is used in the Bayesian estimation method, it is more convenient to use Bayesian estimators of the parameters of the (right) skewed distributions in the decision-making process in medical studies. In many studies, Bayesian estimation has been investigated based on complete and censored samples for different distributions, including by Kundu and Gupta [10], Almogy et al [11], Xie and Gui [12], Cai and Gui [13], Jiang and Gui [14].…”

Section: Introductionmentioning

confidence: 99%

Bayes Estimation for the Rayleigh–Weibull Distribution Based on Progressive Type-II Censored Samples for Cancer Data in Medicine

Akdam

2023

Symmetry

View full text Add to dashboard Cite

The aim of this study is to obtain the Bayes estimators and the maximum likelihood estimators (MLEs) for the unknown parameters of the Rayleigh–Weibull (RW) distribution based on progressive type-II censored samples. The approximate Bayes estimators are calculated using the idea of Lindley, Tierney–Kadane approximations, and also the Markov Chain Monte Carlo (MCMC) method under the squared-error loss function when the Bayes estimators are not handed in explicit forms. In this study, the approximate Bayes estimates are compared with the maximum likelihood estimates in the aspect of the estimated risks (ERs) using Monte Carlo simulation. The asymptotic confidence intervals for the unknown parameters are obtained using the MLEs of parameters. In addition, the coverage probabilities the parametric bootstrap estimates are computed. Real lifetime datasets related to bladder cancer, head and neck cancer, and leukemia are used to illustrate the empirical results belonging to the approximate Bayes estimates, the maximum likelihood estimates, and the parametric bootstrap intervals.

show abstract

Section: Introductionmentioning

confidence: 99%

Bayes Estimation for the Rayleigh–Weibull Distribution Based on Progressive Type-II Censored Samples for Cancer Data in Medicine

Akdam

2023

Symmetry

View full text Add to dashboard Cite

show abstract

“…Since the prior distribution of the parameters is used in the Bayesian estimation method, it is more convenient to use Bayesian estimators of the parameters of the (right) skewed distributions in the decision-making process of the medical studies. In many studies, Bayesian estimation has been investigated based on complete and censored samples for different distributions by Kundu and Gupta [2], Almogy et al [3], Xie and Gui [4], Cai and Gui [5], Jiang and Gui [6].…”

Section: Introductionmentioning

confidence: 99%

Bayes Estimation For The Rayleigh Weibull Distribution Based On Progressive Type-II Censored Samples For Cancer Data In Medicine

Akdam¹

2023

Preprint

View full text Add to dashboard Cite

The aim of this study is to obtain the Bayes estimators and the maximum likelihood estimators (MLEs) for the unknown parameters of the Rayleigh Weibull (RW) distribution based on progres-sive type-II censored samples. The approximate Bayes estimators are calculated using the idea of Lindley and Tierney-Kadane's approximation method under the squared-error loss function when the Bayes estimators are not handed in explicit forms. In this study, the approximate Bayes esti-mates are compared with the maximum likelihood estimates in the aspect of the estimated risks (ERs) using Monte Carlo simulation. In addition, the coverage probabilities of the parametric bootstrap estimates are calculated. Real lifetime data sets belonging to the cancer types as bladder cancer, head and neck cancer, and leukemia are used to illustrate the emprical results belonging to the approximate Bayes estimates, the maximum likelihood estimates, and the parametric bootstrap intervals.

show abstract

“…[47,48] for exponentiated Pareto distribution, Ref. [49,50] for the Kumaraswamy distribution, Ref. [51] for the exponential-Poisson distribution, Ref.…”

Section: Introductionmentioning

confidence: 99%

Bayesian and Non-Bayesian Estimation for a New Extension of Power Topp–Leone Distribution under Ranked Set Sampling with Applications

Alotaibi

Al-Moisheer

Elbatal

et al. 2023

Axioms

View full text Add to dashboard Cite

In this article, we intend to introduce and study a new two-parameter distribution as a new extension of the power Topp–Leone (PTL) distribution called the Kavya–Manoharan PTL (KMPTL) distribution. Several mathematical and statistical features of the KMPTL distribution, such as the quantile function, moments, generating function, and incomplete moments, are calculated. Some measures of entropy are investigated. The cumulative residual Rényi entropy (CRRE) is calculated. To estimate the parameters of the KMPTL distribution, both maximum likelihood and Bayesian estimation methods are used under simple random sample (SRS) and ranked set sampling (RSS). The simulation study was performed to be able to verify the model parameters of the KMPTL distribution using SRS and RSS to demonstrate that RSS is more efficient than SRS. We demonstrated that the KMPTL distribution has more flexibility than the PTL distribution and the other nine competitive statistical distributions: PTL, unit-Gompertz, unit-Lindley, Topp–Leone, unit generalized log Burr XII, unit exponential Pareto, Kumaraswamy, beta, Marshall-Olkin Kumaraswamy distributions employing two real-world datasets.

show abstract

Bayesian Inference for the Parameters of Kumaraswamy Distribution via Ranked Set Sampling

Cited by 9 publications

References 26 publications

Bayes Estimation for the Rayleigh–Weibull Distribution Based on Progressive Type-II Censored Samples for Cancer Data in Medicine

Bayes Estimation for the Rayleigh–Weibull Distribution Based on Progressive Type-II Censored Samples for Cancer Data in Medicine

Bayes Estimation For The Rayleigh Weibull Distribution Based On Progressive Type-II Censored Samples For Cancer Data In Medicine

Bayesian and Non-Bayesian Estimation for a New Extension of Power Topp–Leone Distribution under Ranked Set Sampling with Applications

Contact Info

Product

Resources

About